Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions		9 Months Ended
		Sep. 30, 2015		Sep. 30, 2014
Statement Of Cash Flows [Abstract]
Net earnings available to common stockholders		$ 211.9		$ 191.8
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities
Depreciation and amortization		162.0		205.0
Share-based incentive compensation	[1]	49.1		36.8
Profit sharing expense		26.3		28.3
Loss on debt redemption and refinancing activities		110.7		18.5
Remeasurement loss related to Venezuelan subsidiaries		30.7		18.9
Development grant matter				14.0
Impairment on equity method investment				5.7
Asset impairment				7.4
Provisions for bad debt		3.3		5.4
Provisions for inventory obsolescence		2.9		10.3
Gain from Claims Settlement				(21.1)
Deferred taxes, net		(1.2)		0.2
Net gain on disposals of property and equipment and other		(3.6)		(2.7)
Gain on sale of business		(35.6)
Other non-cash items		(8.3)		4.9
Changes in operating assets and liabilities:
Trade receivables, net		(45.0)		(62.5)
Inventories		(127.7)		(121.8)
Other assets		(34.3)		(28.5)
Accounts payable		115.0		159.1
Settlement agreement and related items		235.2		(929.7)
Other liabilities		(12.8)		(4.8)
Net cash provided by (used in) operating activities		678.6		(464.8)
Cash flows from investing activities:
Capital expenditures		(112.3)		(93.8)
Proceeds from sale of business		75.6
Businesses acquired in purchase transactions, net of cash and cash equivalents acquired		(23.5)		(3.6)
Proceeds from sales of property, equipment and other assets		32.4		8.7
Settlement of foreign currency forward contracts		34.7		9.1
Net cash provided by (used in) investing activities		6.9		(79.6)
Cash flows from financing activities:
Net proceeds from borrowings		257.8		233.8
Dividends paid on common stock		(81.2)		(83.9)
Acquisition of common stock for tax withholding obligations under our Omnibus stock plan and 2005 Contingent Stock Plan		(8.7)		(2.9)
Repurchases of common stock		(685.7)		(134.0)
Payments for debt extinguishment/issuance costs		(108.3)		(12.3)
Net cash (used in) provided by financing activities		(626.1)		0.7
Effect of foreign currency exchange rate changes on cash and cash equivalents		(47.7)		(28.0)
Balance, beginning of period		322.6	[2]	992.4
Net change during the period		11.7		(571.7)
Balance, end of period		334.3		420.7
Supplemental Cash Flow Information:
Interest payments, net of amounts capitalized		169.1		660.6
Income tax payments		78.8		65.8
Stock appreciation rights payments (less amounts included in restructuring payments)		20.0		18.0
Restructuring payments including associated costs		71.7		75.8
Non-cash items:
Transfers of shares of our common stock from treasury for our 2014 and 2013 profit-sharing plan contributions		$ 36.7		33.2
Transfer of shares of our common stock as part of the funding of the Settlement agreement				$ 1.8

[1] The amounts included above do not include the expense related to our U.S. profit sharing contributions made in the form of our common stock or the expense or income related to SARs and other cash-based awards. See Stock Appreciation Rights above for further details of SARs. At September 30, 2015 and September 30, 2014, our other cash-based awards were not material to our condensed consolidated financial positions or results of operations.

[2] During the second quarter of 2015, we completed the sale of our North American foam trays and absorbent pads business. During the first quarter of 2015, the assets and liabilities met the criteria of held for sale classification. Accordingly, we reclassified $42 million of assets and $6 million of liabilities as held for sale as of December 31, 2014. Refer to Note 3, “Divestitures and Acquisitions” of the notes to condensed consolidated financial statements for further details.